According to Evolent Health's latest financial reports the company's current revenue (TTM ) is S$3.37 Billion. In 2023 the company made a revenue of S$2.59 Billion an increase over the revenue in the year 2022 that were of S$1.81 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 (TTM) | S$3.27 B | 26.11% |
2023 | S$2.59 B | 43.1% |
2022 | S$1.81 B | 47.66% |
2021 | S$1.22 B | -2.34% |
2020 | S$1.25 B | 10.14% |
2019 | S$1.14 B | 33.2% |
2018 | S$0.85 B | 47.26% |
2017 | S$0.58 B | 58.13% |
2016 | S$0.36 B | 168.46% |
2015 | S$0.13 B | 416.59% |
2014 | S$26.52 M |